Unlock your academic potential and expand your network by joining us!

Dr. Sameh Soliman

University of sharjah

Share Link

Share

Information

Sameh S.M. Suleiman is an associate professor at the Department of Medicinal Chemistry (pharmacognosy and natural products), College of Pharmacy at the University of Sharjah, United Arab Emirates. He received his PhD from the Pharmaceutical Sciences Department, University of Guelph, Canada, in 2011. He specialises in pharmacognosy and natural products (systems biology and biotechnology). His research interests are as follows: 1) the discovery of novel pharmaceutical products that can be developed for novel drugs, particularly anticancer and antimicrobial drugs; 2) elucidating natural products' biosynthetic pathways to understand their importance in their original host or use their backbone to develop effective medicines; 3) the chemical and biomolecular engineering of semi-natural products, including vaccines and antibodies. In addition, he is a member of the American Chemical Society and the American Society of Microbiology. He is an editor at the Journal of Enzymology and Metabolism. He received a UoS patent (June 2021) for "Novel Anti-SARS-CoV-2 drugs with dual targeting activity”.

Research Keywords & Expertise

Natural Products
anticancer phytonutrie...
Biochemistry and biol...
antimicrobial, antibac...
Biotechnology, Nanotec...

Fingerprints

13%
Natural Products
5%
antimicrobial, antibacterial and antifungal activity

Short Biography

Sameh S.M. Suleiman is an associate professor at the Department of Medicinal Chemistry (pharmacognosy and natural products), College of Pharmacy at the University of Sharjah, United Arab Emirates. He received his PhD from the Pharmaceutical Sciences Department, University of Guelph, Canada, in 2011. He specialises in pharmacognosy and natural products (systems biology and biotechnology). His research interests are as follows: 1) the discovery of novel pharmaceutical products that can be developed for novel drugs, particularly anticancer and antimicrobial drugs; 2) elucidating natural products' biosynthetic pathways to understand their importance in their original host or use their backbone to develop effective medicines; 3) the chemical and biomolecular engineering of semi-natural products, including vaccines and antibodies. In addition, he is a member of the American Chemical Society and the American Society of Microbiology. He is an editor at the Journal of Enzymology and Metabolism. He received a UoS patent (June 2021) for "Novel Anti-SARS-CoV-2 drugs with dual targeting activity”.